Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash Flows From Operating Activities:      
Net loss $ (11,482) $ (3,056) $ (4,486)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:      
Depreciation and amortization 601 513 695
Loss on disposal of assets, net   15 36
Provision for (recovery of) bad debts 291 241 74
Provision for inventory excess and obsolescence 1,132 330 392
Amortization of discount on lines of credit 179 43  
Amortization of discounts on term loan payable     78
Amortization of debt issuance costs 197 91 99
Stock-based compensation 1,609 1,600 1,528
Other equity instruments compensation 106 23 273
Other non-cash compensation 250 250 250
Deferred income taxes (30) 61 53
Incurred and unpaid interest expense 27 19  
Changes in operating assets and liabilities:      
Accounts receivable 264 (3,222) (5,642)
Inventory (1,436) (160) (4,716)
Prepaid expenses and other current assets 56 450 (552)
Customer deposits (297) 417 (5,711)
Accounts payable and accrued liabilities (999) (347) 4,230
Deferred revenue 236 1,068 79
Net cash and cash equivalents used in operating activities (9,296) (1,664) (13,320)
Cash Flows From Investing Activities:      
Additions to property, plant, and equipment (675) (808) (428)
Proceeds from disposal of long-lived assets   124  
Purchased other intangible assets (10) (14)  
Net cash and cash equivalents used in investing activities (685) (698) (428)
Cash Flows From Financing Activities:      
Borrowings under lines of credit 35,100 16,600  
Payments under lines of credit (32,104) (14,963)  
Payments under term loan payable     (2,700)
Payment of debt issuance costs (57) (304)  
Proceeds from exercise of warrants   6 18
Payment to repurchase equity warrants     (130)
Proceeds from equity offering, net of expenses 5,201   17,223
Stock repurchase   (235) (268)
Proceeds from exercise of stock options 707 455 1,244
Net cash and cash equivalents provided by financing activities 8,847 1,559 15,387
Effect of exchange rate changes 31 39 (26)
Increase (decrease) in cash and cash equivalents (1,103) (764) 1,613
Cash and cash equivalents, beginning of year 2,543 3,307 1,694
Cash and cash equivalents, end of year 1,440 2,543 3,307
Supplemental cash flow disclosure:      
Interest paid 220 88 80
Income taxes paid 47 62 44
Supplemental disclosure of non-cash transactions:      
Intangible assets acquired for accounts receivable reduction   $ 200